Cover Image

PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies

Abstract The urgent need for safe, efficacious, and accessible drug treatments to treat coronavirus disease 2019 (COVID‐19) prompted a global effort to evaluate drug repurposing opportunities. Pyronaridine and amodiaquine are both components of approved antimalarials with in vitro activity against s...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nada Abla (Author), Lisa M. Almond (Author), Jennifer J. Bonner (Author), Naomi Richardson (Author), Timothy N. C. Wells (Author), Jörg J. Möhrle (Author)
Format:	Book
Published:	Wiley, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and application of a PBPK modeling strategy to support antimalarial drug development
by: Nada Abla, et al.
Published: (2023)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019)

Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application
by: Elena Lantero, et al.
Published: (2020)

Candidate drug repurposing for malaria: perspectives for optimising clinical trials
by: J. Luis Espinoza
Published: (2025)

Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
by: Prapaporn Chaniad, et al.
Published: (2023)

Antimalarial properties and molecular docking analysis of compounds from Dioscorea bulbifera L. as new antimalarial agent candidates
by: Prapaporn Chaniad, et al.
Published: (2021)

Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?
by: Manuel Ibarra, et al.
Published: (2020)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
by: Joana M. O. Santos, et al.
Published: (2021)

Retrospective Analysis Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation Offers Improvements in Efficiency of the Design of Volunteer Infection Studies for Antimalarial Drug Development
by: Kayla Ann Andrews, et al.
Published: (2021)

A permeability‐ and perfusion‐based PBPK model for improved prediction of concentration‐time profiles
by: Ken Korzekwa, et al.
Published: (2022)

Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes
by: Dan‐Na Wu, et al.
Published: (2022)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
by: Elise Koch, et al.
Published: (2022)

Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
by: Christina A Bulman, et al.
Published: (2015)

Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response
by: Nolan Jackson, et al.
Published: (2022)

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
by: Jia Ning, et al.
Published: (2024)

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability.
by: Manoranjenni eChetty, et al.
Published: (2014)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
by: Filipa Moreira-Silva, et al.
Published: (2020)

Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
by: Rosalba Florio, et al.
Published: (2021)

Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
by: Seung-Hyun Yoon, et al.
Published: (2023)

Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example
by: Xian Pan, et al.
Published: (2024)

Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
by: Christopher A Rice, et al.
Published: (2020)

AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate
by: Marcin Delijewski, et al.
Published: (2021)

Towards a Best Practice Approach in PBPK Modeling: Case Example of Developing a Unified Efavirenz Model Accounting for Induction of CYPs 3A4 and 2B6
by: A Ke, et al.
Published: (2016)

Candidates for Repurposing as Anti-Virulence Agents Based on the Structural Profile Analysis of Microbial Collagenase Inhibitors
by: Georgiana Nitulescu, et al.
Published: (2021)

Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood-Brain Barrier and Assess Target Site Disposition
by: Parsshava Mehta, et al.
Published: (2024)

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019)

Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis
by: Ulku Unal, et al.
Published: (2022)

A single dose of in situ gel formulation of antimalarial drug chloroquine phosphate as a sustained prophylactic candidate for COVID-19
by: Noha Talal Zelai
Published: (2021)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
by: Earnest Oghenesuvwe Erhirhie, et al.
Published: (2021)

PBPK modeling and simulation in drug research and development
by: Xiaomei Zhuang, et al.
Published: (2016)

Variation in chemical composition and antimalarial activities of two samples of Terminalia albida collected from separate sites in Guinea
by: Aissata Camara, et al.
Published: (2021)

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
by: Elizabeth J. Wilk, et al.
Published: (2023)

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes.
by: Brendan D Galvin, et al.
Published: (2014)

Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases
by: Allarakhia M
Published: (2013)

Computational Amendment of Parenteral In Situ Forming Particulates' Characteristics: Design of Experiment and PBPK Physiological Modeling
by: Nada M. El Hoffy, et al.
Published: (2023)

Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010
by: Neelima Mishra, et al.
Published: (2012)

Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against <i>Borrelia burgdorferi</i> In Vitro and In Vivo
by: Hari-Hara S. K. Potula, et al.
Published: (2020)

Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis
by: Chengwei Zhang, et al.
Published: (2020)

The role of antimalarials in lupus nephritis: a review
by: Lee Senq-J, et al.
Published: (2012)